{"nctId":"NCT03300648","briefTitle":"Treating Brain Swelling in Pediatric Cerebral Malaria","startDateStruct":{"date":"2018-01-08","type":"ACTUAL"},"conditions":["Malaria, Cerebral"],"count":57,"armGroups":[{"label":"Usual care","type":"NO_INTERVENTION","interventionNames":[]},{"label":"Mechanical ventilation","type":"EXPERIMENTAL","interventionNames":["Other: Mechanical ventilation"]},{"label":"Hypertonic saline","type":"EXPERIMENTAL","interventionNames":["Drug: Hypertonic saline"]}],"interventions":[{"name":"Mechanical ventilation","otherNames":[]},{"name":"Hypertonic saline","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Peripheral P. falciparum parasitemia of any density\n* Blantyre Coma Score â‰¤2\n* No evidence of meningitis on lumbar puncture\n* Consciousness not regained after correction of hypoglycemia (if hypoglycemia is present)\n* Male or female whose age on the day of screening is between 6 months and 12 years old\n* Severely increased brain volume on magnetic resonance imaging\n* Provision of consent by guardian\n* Willingness to return for 1, 6, and 12 month post-randomization follow-up visits\n\nExclusion Criteria:\n\n* Gross malnutrition as evidenced by peripheral edema, hair color changes, or severe wasting\n* Advanced Human Immunodeficiency Virus (HIV) disease - defined as known HIV positive status and evidence of severe wasting\n* Evidence of recent head trauma by history or physical examination\n* Pneumonia as evidenced by oxygen saturation on room air of \\<85%\n* Gastroenteritis and shock as evidenced by capillary refill \\>3 seconds or skin tenting","healthyVolunteers":false,"sex":"ALL","minimumAge":"6 Months","maximumAge":"12 Years","stdAges":["CHILD"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants Who Died","description":"Alive or dead","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"5","spread":null},{"groupId":"OG002","value":"5","spread":null}]}]}]},{"type":"SECONDARY","title":"Neurodevelopmental Disability","description":"Presence and severity of neurodevelopmental disability in survivors","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"4","spread":null},{"groupId":"OG002","value":"1","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":4,"n":23},"commonTop":[]}}}